---
title: "Goldman Sachs Keeps Their Sell Rating on DBV Technologies (0QAJ)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282152953.md"
description: "Goldman Sachs has maintained a Sell rating on DBV Technologies (0QAJ) with a price target of €1.01. This follows a similar Sell rating from TipRanks. Conversely, Kepler Capital has issued a Buy rating for the same company on the same day."
datetime: "2026-04-09T07:36:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282152953.md)
  - [en](https://longbridge.com/en/news/282152953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282152953.md)
---

# Goldman Sachs Keeps Their Sell Rating on DBV Technologies (0QAJ)

Goldman Sachs analyst maintained a Sell rating on DBV Technologies today and set a price target of €1.01.

### Easter Sale - 70% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

In addition to Goldman Sachs, DBV Technologies also received a Sell from TipRanks – PerPlexity’s PerPlexity Health Care GB in a report issued on March 27. However, on the same day, Kepler Capital maintained a Buy rating on DBV Technologies (LSE: 0QAJ).

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md)

## Related News & Research

- [Does DBV Technologies' (ENXTPA:DBV) ESOP-Linked Share Shelf Highlight a Deeper Funding Strategy Shift?](https://longbridge.com/en/news/285920931.md)
- [NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones | NTHI Stock News](https://longbridge.com/en/news/286931037.md)
- [POET Technologies GAAP EPS of -$0.08 misses by $0.03, revenue of $0.5M beats by $0.25M](https://longbridge.com/en/news/286510324.md)
- [POET Technologies Announces Closing of US$400 Million Investment | POET Stock News](https://longbridge.com/en/news/286785400.md)
- [Maxim Group, Alliance Global, BTIG initiate coverage of NeOnc Technologies](https://longbridge.com/en/news/286930853.md)